Kamel Mohammedi Selected Research

Kamel Mohammedi Research Topics

Disease

36	Type 2 Diabetes Mellitus (MODY) 05/2024 - 01/2009
14	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2022 - 03/2011
9	Hypertension (High Blood Pressure) 02/2024 - 06/2010
9	Diabetic Nephropathies (Diabetic Nephropathy) 10/2023 - 12/2011
8	Peripheral Arterial Disease 05/2024 - 01/2018
8	Chronic Kidney Failure (Chronic Renal Failure) 05/2024 - 11/2013
8	Vascular Diseases (Vascular Disease) 03/2024 - 01/2016
7	Diabetic Foot 05/2024 - 01/2016
5	Obesity 03/2024 - 04/2015
5	Stroke (Strokes) 11/2022 - 07/2012
4	Ulcer 05/2024 - 01/2016
4	Foot Ulcer 10/2023 - 01/2016
4	Myocardial Infarction 11/2022 - 07/2012
4	Hyperglycemia 01/2021 - 04/2011
4	Kidney Diseases (Kidney Disease) 01/2018 - 01/2014
4	Insulin Resistance 01/2017 - 06/2010
3	Prediabetic State (Prediabetes) 05/2024 - 01/2017
3	Neoplasms (Cancer) 05/2024 - 01/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2018
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023 - 01/2018
3	Heart Failure 12/2022 - 12/2018
3	Coronary Disease (Coronary Heart Disease) 12/2018 - 01/2009
3	Albuminuria 01/2018 - 11/2013
3	Hypoglycemia (Reactive Hypoglycemia) 01/2017 - 04/2011
2	Pituitary ACTH Hypersecretion 04/2024 - 01/2023
2	Weight Loss (Weight Reduction) 03/2024 - 01/2021
2	Dyslipidemias (Dyslipidemia) 02/2024 - 10/2023
2	Ischemia 01/2023 - 09/2015
2	Body Weight (Weight, Body) 01/2023 - 11/2022
2	Ketosis 01/2020 - 04/2011
2	Proteinuria 10/2019 - 12/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2016 - 06/2010
1	Dementia (Dementias) 05/2024
1	Cushing Syndrome 04/2024
1	Craniopharyngioma (Craniopharyngiomas) 03/2024
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2022
1	Inflammation (Inflammations) 12/2022
1	Ischemic Stroke 11/2022
1	Dysbiosis 11/2021
1	Transient Ischemic Attack 01/2021

Drug/Important Bio-Agent (IBA)

12	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2009
8	CreatinineIBA 05/2024 - 07/2012
8	Advanced Glycation End ProductsIBA 02/2024 - 01/2019
6	Gliclazide (Diamicron)IBA 01/2021 - 01/2016
6	perindopril drug combination indapamideIBA 01/2021 - 01/2016
5	Biomarkers (Surrogate Marker)IBA 05/2024 - 03/2017
5	Syntex adjuvant formulationIBA 01/2024 - 01/2019
5	Insulin (Novolin)FDA Link 12/2023 - 04/2011
4	Retinaldehyde (Retinal)IBA 05/2024 - 01/2016
4	AlbuminsIBA 12/2022 - 04/2015
4	omega-Chloroacetophenone (Mace)IBA 12/2022 - 01/2017
4	AdrenomedullinIBA 01/2022 - 09/2015
4	Vasopressins (Vasopressin)IBA 01/2018 - 11/2013
4	Advanced Oxidation Protein Products (AOPP)IBA 02/2016 - 01/2014
3	HDL CholesterolIBA 01/2021 - 01/2009
3	LipidsIBA 01/2021 - 01/2020
3	Type I Tumor Necrosis Factor ReceptorsIBA 10/2018 - 03/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 12/2011
3	Superoxide DismutaseIBA 01/2015 - 12/2011
2	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2018
2	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2024 - 01/2023
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2024 - 11/2022
2	Lipoproteins (Lipoprotein)IBA 01/2021 - 09/2016
2	DiureticsIBA 01/2021 - 01/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2020
2	CholesterolIBA 01/2021 - 01/2018
2	8-Hydroxy-2'-DeoxyguanosineIBA 01/2020 - 01/2018
2	Hypoglycemic Agents (Hypoglycemics)IBA 12/2019 - 01/2014
2	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2018 - 03/2017
2	Vasodilator Agents (Vasodilators)IBA 12/2018 - 09/2015
2	pro-brain natriuretic peptide (1-76)IBA 12/2018 - 03/2017
2	Peptides (Polypeptides)IBA 12/2018 - 09/2015
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018 - 03/2017
2	AdiponectinIBA 12/2017 - 03/2011
2	H-cadherin (T-cadherin)IBA 12/2017 - 12/2017
2	IsoprostanesIBA 02/2016 - 01/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2014 - 04/2011
1	Vitamin K FDA Link 05/2024
1	Insulin Glargine (Lantus)FDA Link 05/2024
1	diformyl dapsone (DFD)IBA 05/2024
1	Adrenocorticotropic Hormone (ACTH)FDA Link 04/2024
1	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2024
1	Exenatide (Byetta)FDA Link 03/2024
1	C-Reactive ProteinIBA 02/2024
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 03/2023
1	Leptin ReceptorsIBA 01/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2023
1	semaglutideIBA 01/2023
1	praliciguatIBA 01/2023
1	Soluble Guanylyl CyclaseIBA 01/2023
1	CytokinesIBA 12/2022
1	S100A12 ProteinIBA 12/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2022
1	SodiumIBA 01/2021

Therapy/Procedure

14	Surgical Amputation (Amputations) 03/2024 - 01/2016
4	Therapeutics 05/2024 - 04/2011
2	Bariatric Surgery 01/2022 - 11/2021
2	Orthotic Devices (Orthosis) 01/2020 - 01/2016
2	Light Coagulation 10/2016 - 01/2016
1	Ligation 01/2023